Sweet Financial Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$1.33M Sell
21,209
-5,196
-20% -$303K 0.29% 73
2024
Q2
$1.56M Buy
26,405
+4,003
+18% +$250K 0.36% 61
2024
Q1
$1.79M Buy
22,402
+1,428
+7% +$109K 0.41% 53
2023
Q4
$1.66M Buy
20,974
+3
+0% +$214 0.39% 53
2023
Q3
$1.46M Buy
20,971
+7,877
+60% +$558K 0.39% 57
2023
Q2
$905K Buy
13,094
+503
+4% +$35.8K 0.24% 71
2023
Q1
$936K Buy
12,591
+2,501
+25% +$210K 0.26% 68
2022
Q4
$940K Hold
10,090
0.28% 57
2022
Q3
$962K Buy
10,090
+1
+0% +$99 0.31% 48
2022
Q2
$935K Buy
10,089
+96
+1% +$9.37K 0.29% 49
2022
Q1
$1.01M Buy
9,993
+218
+2% +$22.9K 0.27% 45
2021
Q4
$1.01M Buy
+9,775
New +$903K 0.42% 33

Other funds holding CVS

Sweet Financial Partners's CVS Position: Q3 2024 in Review

Sweet Financial Partners reduced its CVS Health (CVS) stake by 20% in Q3 2024, selling an estimated $303K and leaving 21,209 shares worth $1.33M. The position accounts for 0.29% of the portfolio, ranked #73.

Sweet Financial Partners first reported a position in CVS in Q4 2021 and has held it in 12 quarters since. The position peaked at $1.79M in Q1 2024. 1,843 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

  • Sweet Financial Partners held 21,209 shares of CVS Health worth $1.33M as of Q3 2024.
  • Sweet Financial Partners sold 5,196 CVS Health shares in Q3 2024, an estimated $303K.
  • CVS Health made up 0.29% of Sweet Financial Partners's portfolio in Q3 2024, its #73 holding.
  • Sweet Financial Partners first reported a position in CVS Health in Q4 2021 and has held it in 12 quarters since.
  • Sweet Financial Partners's CVS Health position peaked at $1.79M in Q1 2024.
  • 1,843 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Sweet Financial Partners's 13F filing for Q3 2024, filed 16 Oct 2024.